Cancer treatment method utilizing plasmids suitable for IL-2 expression
US6399588B1 · kind B1 · utility
23Cited by
14References
51Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 2000 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Jul 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2840/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.